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ICA105574 Binds to a Similar Region of the Pore Domain to Induce Oppo-
site Effects on the Gating of EAG and ERG Channels
Vivek Garg1, Anna Stary-Weinzinger2, Michael C. Sanguinetti1.
1University of Utah, Salt Lake City, UT, USA, 2University of Vienna,
Vienna, Austria.
ICA activates hERG1 channels by reducing inactivation, but inhibits hEAG1
channels by inducing inactivation. Molecular modeling suggests that ICA binds
to a pocket located between S5 and S6 in both channels. A mutation in S5
(F557L) or S6 (Y652A) of hERG1 eliminates the activity of ICA, indicating
a key role of these residues in the drug binding site (Garg, et al 2011, Mol.
Pharm. 80: 630). The equivalent mutations in hEAG1 lead to very different ef-
fects. First, F359L hEAG1 channels are activated by ICA (opposite to effects
on wild-type channels). Second, Y464A induces inactivation of hEAG1 chan-
nels, an effect accentuated by ICA. The combined mutation (Y464A/F359L) in
hEAG1 eliminates inactivation, and prevents activation of channels by ICA.
These findings suggest that both Y464 and F359 residues, and perhaps their in-
teraction, are important for intrinsic and ICA-modulated inactivation of hEAG1
channels.
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Modulation of EAG Channel Inactivation by ICA105574
Vivek Garg, Michael Sanguinetti.
University of Utah, Salt Lake City, UT, USA.
Ether-a-go-go (EAG) family potassium channels, including hEAG1 and
hERG1 play an important role in the heart, CNS, cell cycle regulation and can-
cer. ICA-105574 (ICA) was previously reported to activate hERG1 current by
causing a large depolarizing shift in the V0.5 for P-type inactivation (Gerlach et
al,Mol. Pharmacol. 2010, 77: 58). The related hEAG1 channel exhibits little or
no inactivation; however, in the presence of ICA (2 mM) channels exhibit pro-
nounced inactivation (V0.5 =74 mV). Voltage dependence of inactivation and
activation for WT hEAG1 with and without ICA is shown in the figure. At
10 mM ICA, inactivation reduces maxi-
mum current by >80%. Mutation of a sin-
gle Tyr residue in S6 (Y464A) of hEAG1
also induces prominent inactivation which
is accentuated by ICA. Combined muta-
tion of two residues located near the selec-
tivity filter (T432S and A443S) induces
a rapid P-type inactivation similar to
hERG1 that is removed by ICA. Modula-
tion of inactivation by ICA can result in ei-
ther activation or inhibition of EAG1/
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The Acceleration of the Inactivation of Prokaryotic Sodium Channel by
the Formation of C-Terminal 4-Helix Bundle
Katsumasa Irie, Takushi Shimomura, Yoshinori Fujiyoshi.
Kyoto University, Kyoto, Japan.
Voltage-gated sodium channels play essential roles in many important physio-
logical processes, including electric signalling and muscle contraction. There-
fore their activation and inactivation are needed to be strictly regulated.
Here, we show that the cytosolic C-terminal region of NavSulP, a prokaryotic
voltage-gated sodium channel (NavBac) cloned from Sulfitobacter pontiacus,
accelerates C-type inactivation. The crystal structure of the C-terminal region
of NavSulP in a NaK-NavSulP chimera channel at 3.2 A˚ resolution revealed
that the C-terminal region forms a four-helix bundle. Point mutations of the res-
idues of the four-helix bundle, which were involved in intersubunit interactions,
destabilised the tetramer of the channel and reduced the inactivation rate. This
result suggested that the formation of the four-helix bundle accelerates the in-
activation of NavSulP. NavBac inactivation seems to be regulated only by the
C-type inactivation, which is thought to be due to collapse of the selectivity fil-
ter through a conformational change of the activation gate of the inner helix of
the pore domain. The C-terminal four-helix bundle is connected to the inner he-
lix. The increase of the rigidity of the inner helix with the glycine-to-alanine
mutation also reduced the inactivation rate of NavSulP as well as the destabi-
lisation of the four-helix bundle. On the other hand, the glycine-to-alanine
mutation did not destabilize the formation of tetrameric channel, and then
the C-terminal region could maintain the four-helix bundle. It was thought
that the rigidity of inner helix disabled the formation of C-terminal four-
helix bundle from accelerating the C-type inactivation rate.These findings suggest that the formation of four-helix bundle of NavSulP
plays important roles not only in stabilising the tetramer, but also in accelerat-
ing C-type inactivation by promoting a conformational change of the inner
helices of the pore domain.
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Detailed Examination of TRPM7 Channel Mg2D Dependence
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TRPM7, a member of transient receptor potential superfamily of ion channels,
underlies the Mg2þ-inhibited cation currents highly expressed in various cell
types of hematopoietic lineage. TRPM7 channels are sensitive to intracellular
as well as extracellular Mg2þ and other polyvalent cations. The present study
was undertaken to characterize the inhibition of TRPM7 channels by intracel-
lular Mg2þ in detail. In order to generate a dose-response curve for Mg2þi, we
systematically varied the internal Mg2þ concentration and measured the corre-
sponding maximal TRPM7 current amplitude with whole-cell patch clamp in
Jurkat T lymphocytes and HEK293 cells. Mg2þ-containing solutions were
buffered with HEDTA. We tested free Mg2þ concentrations of 100 nM to
400 mM in n R 70 cells. Unexpectedly, we find that the dose-response curve
for Mg2þ is biphasic, yielding IC50 values of ~8 mM and ~200 mM. 300 mM
free Mg2þ is sufficient for complete inhibition of channel activity. This finding
suggests the existence of two inhibitor sites for TRPM7 activity. Since in
whole-cell configuration the channel interior is only exposed to one solution
throughout the recording, it is impossible to separate Mg2þ effect on the likeli-
hood of channel opening from its effect on an already open channel. Moreover,
reversible inhibition cannot be distinguished from time-dependent rundown of
activity. In order to examine the nature of Mg2þ-mediated inhibition more
thoroughly, we recorded TRPM7 channels in inside-out patch configuration.
Membrane patches were excised into a Mg2þ-free bath solution and TRPM7
single-channel activity recorded. Mg2þ was then added to the solution facing
intracellular side of the channel, using rapid application. We observed revers-
ible inhibition by Mg2þ in the 35 - 400 micromolar concentration range and
have characterized changes in single-channel characteristics responsible for
the inhibition. A comparison of Mg2þ and proton sensitivities is also
presented.
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M-Type KD Channel Openers: In Vivo Neuroprotective Role During
Cerebrovascular Stroke
Sonya M. Bierbower, Frank S. Choveau, Mark S. Shapiro.
University of Texas Health Science Center, San Antonio, TX, USA.
Investigations of neuroprotection during ischemic stroke through ‘‘M-chan-
nels’’ could underlie potential treatments, since Kþ channels stabilize resting
potentials by counterbalancing the depolarizing effects of excitatory cation
currents. Produced by combinations of KCNQ2-5 subunits, these voltage-
gated channels, with distinct electrophysiological and pharmacological prop-
erties, play critical roles in control of neuronal excitability and action potential
firing. A known M-channel activator, retigabine (RTG) and other novel
openers, such as NH29 and QO-58, up-regulate M-channels by stabilizing
their open states through distinct molecular mechanisms. We have previously
shown M-channels to be up-regulated by reactive oxygen species (ROS), mol-
ecules commonly produced during and after ischemic cerebrovascular stroke.
We hypothesize that M current-mediated neuronal silencing has a neuroprotec-
tive role by increasing opening of KCNQ channels, thus decreasing neuronal
activity and prolonging activation of cellular cascades that can prevent cell
death. Furthermore, we hypothesize that drugs that shift voltage-dependence
of M-channels toward negative potentials and increase opening, will signifi-
cantly reduce the severity of the ischemic lesion following cerebrovascular
stroke. We used two in vivo mouse models, the first a cerebral infarct pro-
duced by laser-controlled photothrombosis and the second the middle cerebral
artery occlusion (MCAo). Whereas the photothrombosis causes transient is-
chemic attacks in the parietal cortex, the MCAo model produces a catastrophic
stroke in the ipsilateral hemisphere. M-current activity was pharmacologi-
cally altered in both models using RTG, NH29 and QO-58 and the blocker,
XE991. In control, blood vessel photothrombosis caused cell death over
a 24-hour period. Interestingly, application of M-channel activators signifi-
cantly reduced lesion area, whereas XE991 exacerbated the area of cell death.
Thus, this study uses powerful models which may provide novel therapeutics
for commonly-occurring ischemic attacks. We will also show the results of
in vivo imaging and mouse behavioral assays that correlate with histological
data.
